In July 2020, the US placed an initial order for 100 million doses of the Pfizer/BioNTech COVID-19 vaccine, with the option to acquire up to 500 million additional doses.
In December 2020, the US then secured an additional supply of 100 million doses of the jab.
Under the terms of the second agreement, Pfizer/BioNTech said they plan to deliver at least 70 million of the additional doses by 30 June 2021, with the remaining 30 million doses to be delivered no later than 31 July 2021.
For each 100 million doses acquired, the US has paid $1.95bn – the most recent doses will also be acquired for the same amount of money.
“We support the new administration’s plan to vaccinate as many people as quickly as possible because there is an urgent need to help protect people from this virus, here in the US and across the globe,” said Albert Bourla, chairman and chief executive officer of Pfizer…